Answers are grounded in this paper and cite their sources.
For the analysis of broxaterol 1‐(3‐bromoisoxazol‐5‐yl)‐2‐( tert ‐butylamino)ethanol in human plasma and urine an on‐line HPLC‐GC apparatus was used applying the “concurrent solvent evaporation” technique described in previous studies. Broxaterol is quantitatively determined by capillary GC with ECD detection, after extraction from plasma and derivatization. The detection limit of 0.03 ng/ml permits pharmacokinetic studies in man after oral and intravenous administration of the drug.
No takes yet. Share an insight, caveat, or question.
Gianesello et al. (1988) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: